Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir Abbas Tahami Monfared

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Neurology and Therapy|June 19, 2022
The Potential Economic Value of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation ModelingAmir Abbas Tahami Monfared, Ali Tafazzoli, Ameya Chavan, et al.
Neurology and Therapy|March 14, 2022
Alzheimer's Disease: Epidemiology and Clinical ProgressionAmir Abbas Tahami Monfared, Michael J Byrnes, Leigh Ann White, et al.
Neurology and Therapy|February 22, 2022
The Humanistic and Economic Burden of Alzheimer's DiseaseAmir Abbas Tahami Monfared, Michael J Byrnes, Leigh Ann White, et al.
Journal of Alzheimer'S Disease : JAD|August 8, 2022
Stakeholder Insights in Alzheimer's Disease: Natural Language Processing of Social Media ConversationsAmir Abbas Tahami Monfared, Yaakov Stern, Stephen Doogan, et al.
Neurology and Therapy|April 26, 2022
Long-Term Health Outcomes of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation ModelingAmir Abbas Tahami Monfared, Ali Tafazzoli, Weicheng Ye, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthAmir Abbas Tahami Monfared, Raymond Zhang, Quanwu Zhang, et al.
Journal of Managed Care & Specialty Pharmacy|June 12, 2023
Assessing out-of-pocket expenses and indirect costs for the Alzheimer disease continuum in the United StatesAmir Abbas Tahami Monfared, Noemi Hummel, Aastha Chandak, et al.
Journal of Managed Care & Specialty Pharmacy|June 14, 2021
Comparative efficacy of lemborexant and other insomnia treatments: a network meta-analysisHeather McElroy, Beth O'Leary, Michael Adena, et al.
Neurology and Therapy|May 5, 2022
Assessing the Clinical Meaningfulness of the Alzheimer's Disease Composite Score (ADCOMS) ToolAmir Abbas Tahami Monfared, William R Lenderking, Yulia Savva, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 24, 2026
Travel barriers to amyloid-targeting infusion access among older adultsJeremy Burke, Albert Weerman, Mark Hanson, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Neurology and Therapy|June 19, 2022
The Potential Economic Value of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation ModelingAmir Abbas Tahami Monfared, Ali Tafazzoli, Ameya Chavan, et al.
Neurology and Therapy|March 14, 2022
Alzheimer's Disease: Epidemiology and Clinical ProgressionAmir Abbas Tahami Monfared, Michael J Byrnes, Leigh Ann White, et al.
Neurology and Therapy|February 22, 2022
The Humanistic and Economic Burden of Alzheimer's DiseaseAmir Abbas Tahami Monfared, Michael J Byrnes, Leigh Ann White, et al.
Journal of Alzheimer'S Disease : JAD|August 8, 2022
Stakeholder Insights in Alzheimer's Disease: Natural Language Processing of Social Media ConversationsAmir Abbas Tahami Monfared, Yaakov Stern, Stephen Doogan, et al.
Neurology and Therapy|April 26, 2022
Long-Term Health Outcomes of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation ModelingAmir Abbas Tahami Monfared, Ali Tafazzoli, Weicheng Ye, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthAmir Abbas Tahami Monfared, Raymond Zhang, Quanwu Zhang, et al.
Journal of Managed Care & Specialty Pharmacy|June 12, 2023
Assessing out-of-pocket expenses and indirect costs for the Alzheimer disease continuum in the United StatesAmir Abbas Tahami Monfared, Noemi Hummel, Aastha Chandak, et al.
Journal of Managed Care & Specialty Pharmacy|June 14, 2021
Comparative efficacy of lemborexant and other insomnia treatments: a network meta-analysisHeather McElroy, Beth O'Leary, Michael Adena, et al.
Neurology and Therapy|May 5, 2022
Assessing the Clinical Meaningfulness of the Alzheimer's Disease Composite Score (ADCOMS) ToolAmir Abbas Tahami Monfared, William R Lenderking, Yulia Savva, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 24, 2026
Travel barriers to amyloid-targeting infusion access among older adultsJeremy Burke, Albert Weerman, Mark Hanson, et al.
Pageof 6